Filter
471
Text search:
adverse
drug
event
Featured
Recommendations
65
New Publications
103
Language
Document type
No document type
255
Guidelines
86
Studies & Reports
66
Manuals
29
Strategic & Response Plan
15
Fact sheets
8
Training Material
6
Situation Updates
3
App
1
Resource Platforms
1
Infographics
1
Countries / Regions
India
28
Western and Central Europe
23
Global
14
South Africa
13
Latin America and the Carribbean
11
Ethiopia
10
Eastern Europe
10
Nigeria
9
Uganda
9
Kenya
9
Africa
9
Ghana
8
Syria
5
Bangladesh
5
Philippines
4
Nepal
4
Tanzania
4
Rwanda
4
South–East Asia Region
4
Liberia
3
USA
3
Zimbabwe
3
Cambodia
3
Malawi
3
Namibia
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Sierra Leone
2
Lesotho
2
West and Central Africa
2
Asia
2
Tajikistan
2
Congo, Democratic Republic of
1
Cameroon
1
South Sudan
1
Iraq
1
Zambia
1
China
1
Mozambique
1
Argentina
1
Eswatini/ Swaziland
1
North Macedonia
1
Ukraine
1
Botswana
1
East and Southern Africa
1
Western Pacific Region
1
Bhutan
1
Timor Leste/ East Timor
1
Russia
1
Kyrgyzstan
1
Kazakhstan
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
141
Clinical Guidelines
74
Public Health
27
Women & Child Health
25
Key Resources
15
Pharmacy & Technologies
12
Capacity Building
8
Toolboxes
TB
56
Mental Health
50
HIV
44
COVID-19
31
Pharmacy
23
AMR
17
Caregiver
16
NTDs
16
NCDs
10
Ebola & Marburg
9
Rapid Response
9
Planetary Health
9
Conflict
7
Specific Hazards
7
Malaria
6
Natural Hazards
5
Refugee
5
2.0 Rapid Response
5
Disability
4
Polio
4
Global Health Education
4
Cholera
2
Zika
1
Social Ethics
1
Towards the Peoples Health Assembly Book -5
The global burden of disease due to mental disorders continues to rise, especially in low- and middle-income countries (LMIC). In addition to causing a large proportion of morbidity, mental disorders – especially severe mental disorders (SMD) – are linked with poorer health outcomes and increase
...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen
...
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El
...
El presente documento reúne un conjunto de recomendaciones formuladas por la Organización Mundial de la Salud (OMS) y la Organización Panamericana de la Salud (OPS) para ayudar, a los profesionales encargados de los programas de control de vectores de Latinoamérica y el Caribe a nivel nacional,
...
Other disorders
Chapter H.5.1
Stewardship is defined as “the careful and responsible management of something entrusted to one’s care”. It was originally applied in the health-care setting as a tool for optimizing antimicrobial use, termed “antimicrobial stewardship” (AMS). Stewardship has since be
...
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec
...
Tuberculosis continues to represent a severe public health problem in the Region of the Americas, even more so in the case of indigenous peoples, whose TB incidence is much higher than that of the general population. To achieve tuberculosis control in these communities, it is necessary to respond t
...
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
The purpose of this document is to guide clinicians in the care of patients with or at risk of severe illness from influenza virus infection, including those caused by seasonal influenza viruses, pandemic influenza viruses and zoonotic (novel influenza A) viruses.
The COVID-19 pandemic and subsequent public health guidance to reduce the spread of the diseasehave wide-reaching implications for children’s health and wellbeing. Furthermore, paediatric emergency departments(EDs) have rapidly adapted provision of care in response to the pandemic. This qualitativ
...
WHO operational handbook on tuberculosis Module 5: Management of tuberculosis in children and adolescents
recommended
The practical guidance in the operational handbook aims to inform the development or revision of national policies and related implementation guidance on the management of TB in children and adolescents under programmatic circumstances and at different levels of the health system. The operational ha
...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
